Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT04049422

Pulmonary Nodule Cohort

The aim of this study is to identify the clinical features of pulmonary nodules and establish a cohort to identify biomarkers for lung cancer.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Pulmonary Nodule, Solitary Lung Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Solitary Pulmonary Nodule Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age >= 18
  • pulmonary nodule(s) on chest CT, which satisfy at least one of the following two criteria,
  • 4A or above in Lung-RADS v1.1
  • lung cancer risk >= 5% in Brock model

Exclusion criteria

  • already proven lung cancer

Treatment and study plan

Primary outcomes

  1. Incidence of lung cancer

    Time frame: up to 5 years

    incidence of pathologically proven lung cancer

Study contacts

Contact information is provided by the study sponsor or research team.

Young Sik Park, MD

CONTACT

[email protected]

+82-2-2072-7214

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Acronym: liquidNodule

Important dates

Study start
2019
Primary completion
2024
Study completion
2029
First posted
Aug 8, 2019
Registry last updated
Aug 8, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.